Semaglutide at the 2.4mg weight loss dose causes constipation in approximately 24% of users
1 de enero de 2020;25(1):182
D., Brighenti, F., & Porrini, M
The evidence presented here is meant to inform that decision, not make it for you
With the Wegovy pen, some people may later increase beyond the 2.4 mg maintenance dose , up to a maximum of 7.2 mg once weekly , if they've tolerated 2.4 mg for at least four weeks and their provider recommends it for further weight loss
An insurance-based provider will likely save you significant money Need structured coaching and accountability to stay on track with diet and exercise changes Strongly prefer brand-name medications and are uncomfortable with compounded alternatives Require a mobile app for managing your treatment